These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8483424)

  • 1. Postmenopausal oestrogen replacement therapy with subcutaneous oestradiol implants.
    Suhonen S; Sipinen S; Lähteenmäki P; Laine H; Rainio J; Arko H
    Maturitas; 1993 Mar; 16(2):123-31. PubMed ID: 8483424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L; Naessén T; Eriksson K; Rune C
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
    Kapetanakis E; Dmowski WP; Auletta F; Scommegna A
    Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy.
    Panay N; Versi E; Savvas M
    BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
    Thom MH; Collins WP; Studd JW
    Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of piperazine oestrone sulphate on serum oestrogen and gonadotrophin levels in post-menopausal women.
    Isaacs AJ; Havard CW
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):297-302. PubMed ID: 719904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of subcutaneous hormone implants during climacteric.
    Cardozo L; Gibb DM; Tuck SM; Thom MH; Studd JW; Cooper DJ
    Maturitas; 1984 Mar; 5(3):177-84. PubMed ID: 6727691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.
    Grasso A; Baraghini F; Barbieri C; Dalla Vecchia E; Previdi AM; Di Renzo GC; Volpe A
    Maturitas; 1982 Apr; 4(1):19-26. PubMed ID: 6285153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silastic implants releasing estrone in the treatment of climacteric complaints.
    Sipinen S; Lähteenmäki P; Luukkainen T
    Maturitas; 1980 Oct; 2(3):213-24. PubMed ID: 6777635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
    Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
    Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of oestrogen-induced prolactin release by medroxyprogesterone acetate.
    Castelo-Branco C; Palacios S; Martinez de Osaba MJ; Balasch J; Fortuny A; Vanrell J
    Maturitas; 1994 Dec; 20(2-3):145-50. PubMed ID: 7715466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?
    Owen EJ; Siddle NC; McGarrigle HT; Pugh MA
    Br J Obstet Gynaecol; 1992 Aug; 99(8):671-5. PubMed ID: 1327094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotrophin release, bone turnover and climacteric symptoms in postmenopausal women.
    Selby P; McGarrigle HH; Peacock M
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):241-9. PubMed ID: 2512035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of 25-mg estradiol implants in postmenopausal Mexican women.
    del Carmen Cravioto M; Larrea F; Delgado NE; Escobar AR; Díaz-Sánchez V; Domínguez J; de León RP
    Menopause; 2001; 8(5):353-60. PubMed ID: 11528362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women.
    Wide L; Naessén T; Phillips DJ
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.